C-Rad Past Earnings Performance
Past criteria checks 5/6
C-Rad has been growing earnings at an average annual rate of 43.1%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 19.7% per year. C-Rad's return on equity is 18.7%, and it has net margins of 11.9%.
Key information
43.1%
Earnings growth rate
42.2%
EPS growth rate
Medical Equipment Industry Growth | 6.2% |
Revenue growth rate | 19.7% |
Return on equity | 18.7% |
Net Margin | 11.9% |
Next Earnings Update | 07 Feb 2025 |
Recent past performance updates
Recent updates
Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)
Oct 24Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher
Jun 02Returns On Capital Are A Standout For C-Rad (STO:CRAD B)
Mar 01C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem
Feb 15Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?
Feb 03C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear
Jan 19Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?
Oct 28Returns Are Gaining Momentum At C-Rad (STO:CRAD B)
Aug 16Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?
Dec 14Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?
Jul 20Returns Are Gaining Momentum At C-Rad (STO:CRAD B)
May 07Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts
Jan 30C-Rad (STO:CRAD B) Shareholders Will Want The ROCE Trajectory To Continue
Jul 03Will the Promising Trends At C-Rad (STO:CRAD B) Continue?
Mar 05Are C-Rad's (STO:CRAD B) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 07What Percentage Of C-Rad AB (publ) (STO:CRAD B) Shares Do Insiders Own?
Jan 17Revenue & Expenses Breakdown
How C-Rad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 486 | 58 | 259 | 0 |
30 Jun 24 | 497 | 54 | 257 | 0 |
31 Mar 24 | 458 | 48 | 242 | 0 |
31 Dec 23 | 425 | 36 | 229 | 0 |
30 Sep 23 | 385 | 24 | 216 | 0 |
30 Jun 23 | 357 | 20 | 205 | 0 |
31 Mar 23 | 329 | 12 | 195 | 0 |
31 Dec 22 | 301 | 7 | 179 | 0 |
30 Sep 22 | 280 | 14 | 154 | 0 |
30 Jun 22 | 260 | 12 | 143 | 0 |
31 Mar 22 | 257 | 21 | 131 | 0 |
31 Dec 21 | 261 | 25 | 124 | 0 |
30 Sep 21 | 258 | 26 | 120 | 0 |
30 Jun 21 | 247 | 25 | 114 | 0 |
31 Mar 21 | 230 | 17 | 110 | 0 |
31 Dec 20 | 222 | 14 | 109 | 0 |
30 Sep 20 | 198 | -11 | 110 | 0 |
30 Jun 20 | 201 | -16 | 115 | 0 |
31 Mar 20 | 210 | -14 | 120 | 0 |
31 Dec 19 | 205 | -14 | 117 | 0 |
30 Sep 19 | 212 | 23 | 114 | 0 |
30 Jun 19 | 203 | 24 | 111 | 0 |
31 Mar 19 | 204 | 27 | 106 | 0 |
31 Dec 18 | 190 | 21 | 105 | 0 |
30 Sep 18 | 174 | -2 | 101 | 0 |
30 Jun 18 | 161 | -4 | 94 | 0 |
31 Mar 18 | 141 | -10 | 91 | 0 |
31 Dec 17 | 133 | -11 | 88 | 0 |
30 Sep 17 | 118 | -16 | 84 | 0 |
30 Jun 17 | 108 | -23 | 83 | 0 |
31 Mar 17 | 90 | -28 | 80 | 0 |
31 Dec 16 | 83 | -31 | 75 | 0 |
30 Sep 16 | 74 | -33 | 71 | 0 |
30 Jun 16 | 70 | -32 | 67 | 0 |
31 Mar 16 | 73 | -27 | 62 | 0 |
31 Dec 15 | 73 | -21 | 58 | 0 |
30 Sep 15 | 73 | -20 | 57 | 0 |
30 Jun 15 | 66 | -16 | 52 | 0 |
31 Mar 15 | 62 | -8 | 50 | 0 |
31 Dec 14 | 57 | -7 | 47 | 0 |
30 Sep 14 | 56 | -5 | 45 | 0 |
30 Jun 14 | 59 | -4 | 44 | 0 |
31 Mar 14 | 52 | -17 | 44 | 0 |
31 Dec 13 | 49 | -21 | 44 | 0 |
Quality Earnings: CRAD B has high quality earnings.
Growing Profit Margin: CRAD B's current net profit margins (11.9%) are higher than last year (6.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRAD B's earnings have grown significantly by 43.1% per year over the past 5 years.
Accelerating Growth: CRAD B's earnings growth over the past year (140.6%) exceeds its 5-year average (43.1% per year).
Earnings vs Industry: CRAD B earnings growth over the past year (140.6%) exceeded the Medical Equipment industry 31%.
Return on Equity
High ROE: CRAD B's Return on Equity (18.7%) is considered low.